Day Zero Diagnostics

Name: Upstatement
Price range: $

Developing technologies to help control healthcare-associated infections (HAIs), where antibiotic resistant organisms can be especially dangerous.

2020 President’s Innovation Challenge Finalist

About Day Zero Diagnostics

School

Harvard Graduate School of Arts and Sciences, Harvard T.H. Chan School of Public Health, Harvard College, Harvard Medical School, Harvard Business School

Connect

Email, Website

bioMieux acquires assets of Day Zero Diagnostics

06.16.2025
Day Zero shares AI-based approach to antimicrobial susceptibility testing

06.14.2025
Lab Pulse
AI could help speed antibiotic selection for sepsis

06.20.2024
Healio
Day Zero Diagnostics inks new partnership for bloodstream infection diagnostics

11.14.2023
Mass Device
Day Zero Diagnostics Closes $16M Financing Round

09.20.2023
360 Dx

Day Zero Diagnostics

2023 Venture Accomplishments from the Harvard Innovation Labs

In The Press View all

Awards & Affiliations

Related Articles

2023 Venture Accomplishments from the Harvard Innovation Labs

In The Press View all

More Ventures

Maka Media

Foxino

LungSphere

Hago Energetics